Compare SXI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXI | XENE |
|---|---|---|
| Founded | 1955 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.2B |
| IPO Year | 1994 | 2014 |
| Metric | SXI | XENE |
|---|---|---|
| Price | $259.76 | $53.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | ★ $281.33 | $67.17 |
| AVG Volume (30 Days) | 150.5K | ★ 1.7M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $604,535,000.00 | $311,000.00 |
| Revenue This Year | $15.98 | N/A |
| Revenue Next Year | $8.09 | $2,823.63 |
| P/E Ratio | $176.47 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $128.85 | $26.74 |
| 52 Week High | $270.87 | $62.91 |
| Indicator | SXI | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 58.07 |
| Support Level | $243.25 | $38.36 |
| Resistance Level | $267.47 | $62.91 |
| Average True Range (ATR) | 10.26 | 2.15 |
| MACD | -0.64 | -0.17 |
| Stochastic Oscillator | 61.20 | 56.44 |
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.